Inactive Instrument

Insiders Bellerophon Therapeutics LLC Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
-	-

05-02	North American Morning Briefing : Stock Futures -2-	DJ
04-25	North American Morning Briefing : More Tech -2-	DJ

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bellerophon Therapeutics, Inc. Announces Resignation of Mary Ann Cloyd and Scott Bruder as Members of Board of Directors	03-04	CI
Bellerophon Therapeutics, Inc. Announces Executive Changes	11-21	CI
Bellerophon Therapeutics, Inc. Announces Executive Changes	11-21	CI
Bellerophon Therapeutics Insider Sold Shares Worth $111,776, According to a Recent SEC Filing	23-10-17	MT
Bellerophon Therapeutics, Inc. Announces Resignation of Theodore Wang as a Member of the Company's Board	23-10-13	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Crispin Teufel as Board of Director	23-07-14	CI
Bellerophon Therapeutics Announces Separation of Peter Fernandes as Chief Executive Officer, Effective July 15, 2023	23-06-29	CI
Bellerophon Therapeutics, Inc. Appoints Peter Fernandes, as Principal Financial and Accounting Officer	23-05-11	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Nicholas Laccona as Principal Financial and Accounting Officer	23-04-25	CI
Bellerophon Therapeutics, Inc. Announces New Board Appointment	22-06-07	CI
Avantor Names Jonathan Peacock Chairman	22-05-13	MT
Bellerophon Therapeutics, Inc. Appoints Peter Fernandes as Interim Principal Executive Officer	21-11-12	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Fabian Tenenbaum as A Director	21-10-12	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Chief Executive Officer	21-10-12	CI
Bellerophon Therapeutics, Inc. Appoints Nicholas Laccona as Principal Financial Officer and Principal Accounting Officer	21-10-06	CI
Bellerophon Therapeutics : Chief Financial Officer Assaf Korner to Resign Next Month	21-08-31	MT
Assaf Korner Intent to Resign as Chief Financial Officer of Bellerophon Therapeutics, Inc, Effective September 10, 2021	21-08-31	CI
Bellerophon Therapeutics, Inc. Announces Executive Changes	21-05-26	CI
Jonathan Peacock Intends Not Stand for Re-Election to the Board of Bellerophon Therapeutics, Inc	21-03-31	CI
Insider Trends: Selling By Insiders Lingers at Bellerophon Therapeutics	21-03-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bellerophon Therapeutics LLC Nasdaq

Equities

Insiders

Filters